 |
|
|
2018.04.02 Erenumab (Aimovig) - Training Completion Survey
|
|
|
- Please select one: *
|
- My Trainer was:*
|
- I would describe the overall pace of the training as:*
|
- The trainer's communication style aided my learning (tone, volume, eye contact, gestures).*
|
- The trainer managed the classroom well (responding to questions, managing time, handling difficult participants).*
|
- The trainer helped me understand the "why" behind the topics that were presented (topic introductions, benefit statements).*
|
- The trainer facilitated activities effectively (stated purpose, clear instructions, debriefs).*
|
- The trainer effectively helped me learn new knowledge/job skills, or reinforced previous knowledge/job skills.*
|
- The way in which the class was conducted was:*
|
- The information provided helped me learn new knowledge/job skills, or reinforced previous knowledge/job skills.*
|
- The training room provided a comfortable place for me to learn.*
|
- The system(s) I used to practice job tasks functioned well all the time.*
|
- I would describe my level of confidence to accurately follow procedures as:*
|
- I would describe my level of confidence to use system(s) as:*
|
- I would describe my level of confidence to correctly use tools (call guidelines, FAQs, WIs, etc) as:*
|
- I would describe my level of confidence to correctly explain program requirements as:*
|
- I would describe my level of confidence to identify and report lack of compliance with program requirements as:*
|
- I would describe my level of confidence to identify and report potential adverse events and product complaints as:*
|
- Overall, I would describe this learning experience as:*
|
- Use the space provided to add your additional feedback.
|
